Tilray Brands, Inc. operates as a global lifestyle and consumer packaged goods company spanning cannabis, craft beverages, hemp-based foods and wellness products. News about TLRY commonly covers product launches, brand refreshes and retail distribution across beverage and food subsidiaries such as BrewDog, 10 Barrel Brewing, SweetWater Brewing Company, Widmer Brothers Brewing and Manitoba Harvest.
Company updates also address Tilray Medical, international medical cannabis markets, Canadian adult-use and medical cannabis activity, quarterly operating results, acquisitions and capital actions. Recurring coverage links Tilray’s cannabis platform with its beverage and wellness portfolio across North America, Europe and other international markets.
Tilray Brands (TLRY) subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing and Hop Valley Brewing expanded their partnership with the Portland Trail Blazers. The brands are the team’s Official Craft Beer Partners, and 10 Barrel becomes its first Official Canned Cocktail Partner.
The partnership extends across Moda Center and the Rip City Bar Network, continuing Hop Valley’s sponsorship and welcoming back 10 Barrel and Widmer Brothers. Schonely’s Taproom will become Schonely’s Oregon Beer Hall, while a Pub Beer bar will replace the former Low Bar. Official watch parties and team entertainment appearances are also planned at 10 Barrel’s Portland pub.
Tilray Brands (TLRY) subsidiary Breckenridge Distillery launched the 2 Mile High Whiskey Club, a paid membership offering exclusive whiskey releases.
Membership costs $199 per quarter and includes two 750mL bottles each season, alongside virtual tastings, cocktail sessions and access to distillery events. Members receive 10% off at the distillery restaurant and 15% off merchandise and bottles in-store. Planned selections include Holiday Blend, a Merlot Cask Finish Whiskey and a Master Distiller's pick of Powder Hound Whiskey.
Tilray Brands (TLRY) plans to consolidate Canadian cannabis operations, targeting approximately US$10 million in annualized cost savings by fiscal 2028's end. Cultivation will move from Foss to Masson, with pre-roll production moving to Cayuga. Foss operations are expected to conclude by January 31, 2027, through a phased transition.
Masson's annual cultivation capacity can increase from approximately 32.5 to 50 metric tonnes. Tilray expects the facility to reestablish EU-GMP certification, a manufacturing standard for medical markets, in calendar 2027 and anticipates uninterrupted brand supply during the transition.
Fiscal 2027 Adjusted EBITDA guidance, an adjusted earnings measure, rises to $70 million–$75 million from $68 million–$75 million. Pre-rolls account for approximately one-third of Canadian adult-use sales and grew 28% in fiscal 2026. Tilray expects international cannabis shipments above 8 metric tonnes this fiscal year.
Tilray Brands (TLRY) subsidiary Breckenridge Distillery and University of Denver Athletics released a limited-edition bourbon celebrating Denver’s NCAA men’s hockey championship.
The 230-bottle release costs $179.99 per bottle, with $100 from every bottle sold benefiting the Denver Men’s Ice Hockey Scholarship. The whiskey commemorates the program’s record 11th national championship, won on April 11, 2026. It is available at Bonnie Brae Liquor and Mondo Vino in Denver, with home delivery where permitted.
Tilray Brands (TLRY) announced another phase of its U.S. beverage restructuring, targeting approximately $20 million in annualized cost savings. The company targets those savings by the end of fiscal 2028 and expects most incremental benefits by then. Its U.S. brewing footprint has been consolidated from 10 facilities to six. Since January 2025, its distributor network has shrunk approximately 9%, and its product assortment has fallen approximately 28%.
Tilray reaffirmed fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million, an adjusted earnings measure that already incorporates anticipated benefits from cost reductions underway. Plans include selling redundant brewing and warehouse facilities. Its exclusive U.S. brewing and commercial partnership with Carlsberg launches January 1, 2027, targeting approximately one million cases in its first year through existing production and distribution infrastructure.
Tilray Brands (TLRY) subsidiary Blue Point Brewing will host its annual Cask Ales Festival in Patchogue on November 7, 2026.
The 22nd annual event runs from 2 to 6 p.m. at Blue Point Brewpub, 225 West Main Street. General admission costs $40 and includes a 5-ounce tasting glass and beer samples from more than 100 casks. Local food trucks and live music will accompany the festival, with music continuing indoors from 6 to 10 p.m. The event is open to guests ages 21 and older and will take place rain or shine.
Tilray Brands (TLRY) subsidiary BrewDog and West Ham United unveiled Boleyn Brew, a beer developed with the football club’s supporters. Limited-edition cans are available online while stocks last, with the beer making its London Stadium debut at Saturday’s match against Southampton.
Supporters helped shape the beer’s style, branding and name, choosing a reference to West Ham’s former Boleyn Ground. The launch builds on BrewDog’s existing role as West Ham’s Official Beer Partner and follows the club-branded Claret & Brew release in November 2025.
Tilray Brands (TLRY) announced that its SweetWater Brewing brand launched a concert sweepstakes offering fans tickets to selected AEG venues in Georgia. The promotion runs through December 31, 2026, with one winner selected in each of two entry periods. Each winner and an adult guest can choose a 2026–2027 concert at Georgia Theatre, The Eastern, Variety Playhouse, or Terminal West. Prizes include a travel gift card, with a lower amount for winners living within 50 miles of their selected venue. Entry is limited to eligible residents aged 21 or older; no purchase is necessary.
Tilray Brands (TLRY) received regulatory approval for its Tilray Medical laboratory in Portugal to conduct critical quality testing in-house.
INFARMED, Portugal’s medicines and health products authority, authorized microbiological and chemical/physical testing at the Cantanhede facility, which is certified under European Union good manufacturing practice standards (EU-GMP). Tilray said reducing reliance on third-party testing for cannabis flower lots can lower batch-release costs and shorten testing timelines, moving products more efficiently from harvest to sale. The approval follows increased output at the Portugal facility and expansion of Tilray Medical-branded cannabis medicines in the United Kingdom through Lyphe Clinic and Lyphe Dispensary.
Tilray Brands (TLRY) reported record first-quarter fiscal 2027 net revenue of $257.1 million, up 23% from the prior-year quarter. For the quarter ended August 31, 2026, gross profit rose 35% to $77.5 million, and gross margin increased to 30% from 27%. Beverage revenue rose 82% to $101.5 million, reflecting the BrewDog acquisition; distribution revenue increased 14% to $84.3 million. Cannabis revenue fell to $56.1 million from $64.5 million.
Net loss was $40.0 million, versus net income of $1.513 million a year earlier; loss per share was $0.32. Adjusted EBITDA, a non-GAAP earnings measure, declined to $9.2 million from $10.2 million. Tilray reduced outstanding debt by $42 million fiscal year-to-date and ended the quarter with $221.4 million in cash, restricted cash and marketable securities. The company reaffirmed its $68 million to $75 million adjusted EBITDA expectation for the fiscal year ending May 31, 2027.